Seek Labs

Coming – November 18

One Platform. Multiple Diseases. New Possibilities.

Date and Time

November 18

–

4:00 PM ET / 1:00 PM PT

Details will be shared with confirmed attendees

About this Event

An Executive Briefing with Jared Bauer, CEO of Seek Labs

What if the same underlying technology could help scientists develop new approaches to treating infectious diseases, cancer, and other serious medical conditions?

Seek Labs is building a programmable biotechnology platform designed to make that possibility a reality.

At its core is BioSeeker, an AI-powered genomic intelligence engine that analyzes genetic sequences to identify vulnerabilities associated with disease. Those insights support two complementary technologies: Sequence Ablation Therapeutics (SAT), an investigational CRISPR-based therapeutic platform, and SeekIt Diagnostics, a molecular detection platform.

Together, these technologies are designed to support a more adaptable approach to disease detection and therapeutic development.

Recent developments highlight the expanding scope of Seek Labs’ work:
  • Expanding into oncology: An agreement with the Two2Ten Foundation provides up to $3 million to support preclinical research applying SAT technology to cancer.
  • Advancing global health: Through its Clinton Global Initiative Commitment to Action, Seek Labs is working with partners to explore new therapeutic approaches for neglected infectious diseases.
  • Building a broader platform: BioSeeker has mapped more than 145 infectious diseases, creating a growing foundation of genomic intelligence for future research and development.
  • Developing diagnostic applications: SeekIt is being developed to bring molecular diagnostic capabilities closer to the point of care.

Join Jared Bauer, CEO and Co-Founder of Seek Labs, and SVP of Research and Development, Alison O’Mahony for an executive briefing exploring:
  • How Seek Labs’ integrated technology platform works and what differentiates its approach.
  • The significance of the company’s expansion into oncology.
  • Recent research developments, collaborations, and milestones.
  • Opportunities to apply its technologies across multiple disease categories.
  • The company’s development priorities and long-term vision.

This discussion offers family offices and members of the Force network an opportunity to learn more about a company exploring a fundamentally different approach to diagnosing and treating disease.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.